Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy

American Journal of Hypertension

Volumn 18, Issue 1, 2005, Pages 13-17

  Fujisawa, Tomomi ^a   Ikegami, Hiroshi ^a   Ono, Masaya ^a   Nishino, Masanori ^a   Noso, Shinsuke ^a   Kawabata, Yumiko ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme; renin angiotensin system

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; MEASUREMENT; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PARAMETER; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME; URINALYSIS; URINE LEVEL;

AGED; ALBUMINURIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMIDAZOLIDINES; MALE; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME;

EID: 13244292471     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.08.001     Document Type: Article

References (24)

1. S. Anderson, B.M. Brenner Role of intraglomerular hypertension in the initiation and progression of renal disease N.M. Kaplan B.M. Brenner J.H. Laragh The Kidney in Hypertension 1987 Raven Press New York 67 76
2. K.D. Mitchell, B. Braam, L.G. Navar Hypertensiogenic mechanisms mediated by renal actions of renin-angiotensin system Hypertension 19 1992 I-18 I-27
3. K.M. Denton, W.P. Anderson, R. Sinniah Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole Am J Physiol Regul Integr Comp Physiol 279 2000 R629 R638
4. R. Zatz, B.R. Dunn, T.W. Meyer, S. Anderson, H.G. Rennke, B.M. Brenner, R.L. De Graphenried, J.L. Noddin, A.W. Nunn, D. Standstorm Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension J Clin Invest 77 1986 1925 1930
5. American Diabetes Association Treatment of hypertension in adults with diabetes Diabetes Care 27 Suppl 1 2004 S65 S67
6. D. Ljutic, P. Kes The role of arterial hypertension in the progression of non-diabetic glomerular diseases Nephrol Dial Transplant 18 Suppl 5 2003 v28 v30
7. S. Sonkodi, A. Mogyorosi Treatment of diabetic nephropathy with angiotensin II blockers Nephrol Dial Transplant 18 Suppl 5 2003 v21 v23
8. C.E. Mogensen, S. Neldam, Ilkka Tikkanen, S. Oren, R. Viskoper, R.W. Watts, M.E. Cooper Randomized controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes the candesartan and lisinopril microalbuminuria (CALM) study Br Med J 321 2000 1440 1444
9. K. Rossing, B. Jensen, P.K. Christensen, H.H. Parving Dual blockade of the renin-angiotensin system in diabetic nephropathy Diabetes Care 25 2002 95 100
10. J. Deira, H. Diaz, J. Grande Complete blockade of the renin-angiotensin system in patients with advanced diabetic nephropathy Diabetes Care 26 2003 1635 1636
11. K. Rossing, P. Jacobsen, L. Pietraszek, H.H. Parving Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in nephropathy a randomized double-blind crossover trial Diabetes Care 26 2003 2268 2274
12. P. Jacobsen, S. Andersen, B.R. Jensen, H.H. Parving Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy J Am Soc Nephrol 14 2003 992 999
13. D. Russo, A. Pisani, M.M. Balletta, L.D. Nicola, F.A. Savino, M. Andreucci, R. Minutolo Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy Am J Kidney Dis 33 1999 851 856
14. N. Nakao, A. Yoshimura, H. Morita, M. Takada, T. Kayano, T. Ideura Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE) a randomized controlled trial Lancet 361 2003 117 123
15. American Diabetes Association Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
16. L.A. Hebert, M.E. Falkenhain, N.S. Nahman, F.G. Cosio, T.M. O'Dorisio Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy Am J Nephrol 19 1999 1 6
17. J. Stassen, P. Lijnen, R. Fagard, L.J. Verschueren, A. Amery Rise in plasma concentration of aldosterone during long-term angiotensin II suppression J Endocrinol 91 1981 457 465
18. J.L. Zhuo, F.A. Mendelsohn, M. Ohishi Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease Hypertension 39 2002 634 638
19. N.K. Hollenberg, N.D.L. Fisher, D.A. Price Pathways for angiotensin II generation in intact human tissue evidence from comparative pharmacological interruption of the renin system Hypertension 32 1998 387 392
20. T. Mitsui, S. Chishima, A. Odawara, A. Ohtani Imidapril, an angiotensin-converting enzyme inhibitor, inhibits thrombosis via reduction in aortic plasminogen activator inhibitor type-1 levels in spontaneously hypertensive rats Biol Pharm Bull 22 1999 863 865
21. N. Komine, S. Khang, L.M. Wead, R.C. Blantz, F.B. Gabbai Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels Am J Kidney Dis 39 2002 159 164
22. R. Agarwal, S. Siva, S.R. Dunn, K. Sharma Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels Am J Kidney Dis 39 2002 486 492
23. H.M. Siragy, M. Gasparo, M. El-Kersh, R.M. Carey Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP Hypertension 38 2001 183 186
24. H.M. Siragy, N.L. Howell, N.V. Ragsdale, R.M. Carey Renal interstitial fluid angiotensin Hypertension 25 1995 1021 1024